Alliance Wealth Advisors (Utah)’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.19M Sell
15,173
-6,101
-29% -$492K 0.22% 61
2026
Q1
$1.84M Sell
21,274
-10,029
-32% -$961K 0.4% 44
2025
Q4
$3.01M Sell
31,303
-15,236
-33% -$1.48M 0.65% 40
2025
Q3
$4.43M Sell
46,539
-2,282
-5% -$210K 1.04% 22
2025
Q2
$4.26M Sell
48,821
-1,307
-3% -$111K 1.02% 23
2025
Q1
$4.5M Sell
50,128
-4,328
-8% -$387K 1.18% 15
2024
Q4
$4.35M Buy
54,456
+145
+0.3% +$12.6K 1.12% 17
2024
Q3
$4.89M Buy
54,311
+3,626
+7% +$305K 1.29% 13
2024
Q2
$3.99M Buy
50,685
+1,403
+3% +$115K 1.17% 18
2024
Q1
$4.29M Buy
49,282
+3,587
+8% +$306K 1.28% 14
2023
Q4
$3.76M Buy
45,695
+1,068
+2% +$81.4K 1.26% 18
2023
Q3
$3.5M Buy
44,627
+3,684
+9% +$308K 1.3% 17
2023
Q2
$3.61M Buy
40,943
+23,944
+141% +$2.06M 1.34% 15
2023
Q1
$1.37M Buy
16,999
+5,853
+53% +$477K 0.55% 56
2022
Q4
$866K Buy
+11,146
New +$903K 0.39% 70

Other funds holding MDT

Alliance Wealth Advisors (Utah)'s MDT Position: Q2 2026 in Review

Alliance Wealth Advisors (Utah) reduced its Medtronic (MDT) stake by 29% in Q2 2026, selling an estimated $492K and leaving 15,173 shares worth $1.19M. The position accounts for 0.22% of the portfolio, ranked #61.

Alliance Wealth Advisors (Utah) first reported a position in MDT in Q4 2022 and has held it in 15 quarters since. The position peaked at $4.89M in Q3 2024. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Alliance Wealth Advisors (Utah) held 15,173 shares of Medtronic worth $1.19M as of Q2 2026.
  • Alliance Wealth Advisors (Utah) sold 6,101 Medtronic shares in Q2 2026, an estimated $492K.
  • Medtronic made up 0.22% of Alliance Wealth Advisors (Utah)'s portfolio in Q2 2026, its #61 holding.
  • Alliance Wealth Advisors (Utah) first reported a position in Medtronic in Q4 2022 and has held it in 15 quarters since.
  • Alliance Wealth Advisors (Utah)'s Medtronic position peaked at $4.89M in Q3 2024.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Alliance Wealth Advisors (Utah)'s 13F filing for Q2 2026, filed 23 Jul 2026.